Virogin Biotech competitorsClear all

Virogin Biotech's top competitors include SQZ Biotech, Eutilex, Foghorn Therapeutics and Gossamer Bio.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Virogin Biotech
Virogin Biotech
Virogin Biotech is a company that specializes in oncolytic virotherapy.
SQZ Biotech
SQZ Biotech
SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.
Eutilex
Eutilex
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Gossamer Bio
Gossamer Bio
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
Founding Date
Founding Date
2015
Founding Date
2013
Founding Date
2015
Founding Date
2016
Founding Date
2015
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Vancouver, CA HQ
Locations
Watertown, US HQ
Locations
KR HQ
Locations
Cambridge, US HQ
Cambridge, US
Locations
San Diego, US HQ
Dublin 2, IE
Employees
Employees
36
Employees
101
Employees
108
Employees
85
Employees
11820% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
319.4 m
Valuation ($)
N/A
Valuation ($)
409.5 m
Valuation ($)
784.5 m
Twitter followers
Twitter followers
38
Twitter followers
574
Twitter followers
N/A
Twitter followers
711
Twitter followers
352
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
11
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
7.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
6.5
Average likes per tweet (last 30 days)
0.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
54.55%
Alexa Website Rank
Alexa Website Rank
326221
Alexa Website Rank
401754
Alexa Website Rank
N/A
Alexa Website Rank
194154
Alexa Website Rank
535317
Employee Rating
Employee Rating
N/A
Employee Rating
3.7
Employee Rating
N/A
Employee Rating
2.9
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$21m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$430k (FY, 2020)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($50.5m) (FY, 2020)
Net income
N/A
Net income
($68.8m) (FY, 2020)
Net income
($243.4m) (FY, 2020)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 233.4m
Total funding raised
$ 18.9m
Total funding raised
$ 50m
Total funding raised
$ 480m
For sources of this data, please see the company profile

View company profiles

SQZ Biotech
HQ
Watertown, US
Employees
101

SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.

View company
Eutilex
HQ
KR
Employees
108

Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.

View company
Foghorn Therapeutics
HQ
Cambridge, US
Employees
85

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase

Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.

View company